Imperial College London

Dr Robert Boyle

Faculty of MedicineNational Heart & Lung Institute

Reader in Paediatric Allergy
 
 
 
//

Contact

 

+44 (0)20 3312 7892r.boyle Website

 
 
//

Location

 

Paediatric Research UnitQueen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Bramer:2021:10.1111/mcn.13128,
author = {Bramer, S and Boyle, R and Weaver, G and Shenker, N},
doi = {10.1111/mcn.13128},
journal = {Maternal and Child Nutrition},
pages = {1--9},
title = {Use of donor human milk in nonhospitalized infants: An infant growth study},
url = {http://dx.doi.org/10.1111/mcn.13128},
volume = {17},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - When mother's own milk (MOM) is unavailable or insufficient, donor human milk (DHM) is recommended as the next best alternative for low birthweight infants. DHM use for healthy, term infants is increasing, but evidence for growth and tolerability is limited. This retrospective study evaluated growth in term infants in the community who received DHM from a UK milk bank. Mothers of infants receiving DHM between 2017 and 2019 were contacted (n = 49), and 31 (63.2%) agreed to participate. Fourteen infants received DHM as a supplement to other feeds (MOM and/or infant formula) and 17 were exclusively fed DHM where breastfeeding was impossible (range: 3–6 weeks). Growth was assessed by deriving zscores using the WHO standard for infant growth and compared with 200 exclusively breastfed infants. Multivariate regression analysis revealed no feeding methodspecific association between zscore and age, nor between weight and age, suggesting that zscores and growth velocity were not affected by feeding exclusive MOM, supplemental DHM or exclusive DHM. DHM was welltolerated with no adverse events that led to early cessation. After receiving supplemental DHM group, 63% of infants whose mothers had no physical barrier to breastfeeding (5/8 infants) were exclusively breastfed. This novel study reports adequate growth outcomes of healthy nonhospitalized infants receiving DHM, either as the sole milk source or supplement. Prospective studies are needed to confirm whether DHM is a suitable feeding alternative for term infants in the community, optimal durations, as well as the impact of DHM availability on breastfeeding rates and maternal mental health.
AU - Bramer,S
AU - Boyle,R
AU - Weaver,G
AU - Shenker,N
DO - 10.1111/mcn.13128
EP - 9
PY - 2021///
SN - 1740-8695
SP - 1
TI - Use of donor human milk in nonhospitalized infants: An infant growth study
T2 - Maternal and Child Nutrition
UR - http://dx.doi.org/10.1111/mcn.13128
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000604990600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://onlinelibrary.wiley.com/doi/10.1111/mcn.13128
UR - http://hdl.handle.net/10044/1/86098
VL - 17
ER -